Canopy Biosciences logo — Providing access to cutting-edge spatial biology and multi-o...

Canopy Biosciences

Providing access to cutting-edge spatial biology and multi-omic tools.

Founded 2016 United States United States 26 employees Series Unknown Total: $4.40M Biopharma, Biotechnology +2

General Information

Company Name Canopy Biosciences
Founded Year 2016
Location United States United States +4
Employees 26
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Series Unknown
Social

Get notified when Canopy Biosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Canopy Biosciences

Canopy Biosciences is a biotech startup that aims to revolutionize the field of spatial biology and multi-omic tools. Acquired by Bruker, the company is driven by its mission to empower innovation by providing biomedical researchers with cutting-edge technologies to accelerate scientific discovery. Its proprietary technology, ChipCytometry™, offers a quantitative multiplex immunofluorescence imaging method for the spatial analysis of complex tissues and mapping of cell populations with single-cell resolution. Supported by Canopy Spatial Services™ with a CLIA-certified laboratory, the company offers a unique collection of spatial and single-cell technologies that accelerate the understanding of cellular diversity and interaction. Established in 2016 and headquartered in the United States, Canopy Biosciences secured a Venture Round investment on 30 April 2019 from Ampersand Capital Partners. With its focus on propelling scientific discovery and its backing from notable investors, Canopy Biosciences is poised to make significant contributions to the biotech and healthcare industries. Learn more at CanopyBiosciences.com.

Taxonomy: Spatial Biology, Multi-omic Tools, Gene Editing, Personalized Medicine, Transcriptomics, CLIA, CRO Services, Multiplex Imaging, Digital Pathology, Immunofluorescence, Tissue Analysis, Proteomics, Spatial Phenotyping

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Unknown 1 30 Apr 2019
Series A $2.40M 6 Pinpoint Holdings, Greenleaf Seed Fund 22 May 2018
Seed Round $2.00M 1 30 Jan 2017

Canopy Biosciences Alternatives & Competitors

Canopy Biosciences vs

The leading single-cell sequencing CRO providing high-impact insights to biopharma, health systems,...

32 employees
Biotechnology, Health Care
Canopy Biosciences vs

Biology is Spatial

12 employees
Canopy Biosciences vs
Vizgen
Vizgen United States

Confidently take your research to new depths with MERSCOPE Ultra integrating single-cell and spatial...

Series E
153 employees
Biotechnology, Health Care

FAQ About Canopy Biosciences

Providing access to cutting-edge spatial biology and multi-omic tools.
Canopy Biosciences was founded in 2016.
Canopy Biosciences is headquartered in United States.
Canopy Biosciences operates in the following industries: Biopharma, Biotechnology, Health Care, Life Sciences.
Canopy Biosciences has approximately 26 employees.
Canopy Biosciences has completed 3 funding rounds, raising a total of $4.40M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Canopy Biosciences include Single Cell Discoveries, Spatial Genomics, Inc., Vizgen, NanoString Technologies, Inc., SCellex. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Canopy Biosciences and Single Cell Discoveries are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Canopy Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy